Imbruvica 140mg Capsule
Marketer
Janssen Pharmaceuticals
Salt Composition
Ibrutinib (140mg)
Overview Imbruvica 140mg Capsule
Ibrutinib 140mg capsules treat mantle cell lymphoma and a type of blood cancer (chronic lymphocytic leukemia), including cases that have already undergone at least one prior treatment regimen. Dosage is determined by your physician. Treatment length depends on individual response, monitored through regular blood tests to track blood cell counts. This medication can lower blood cell levels, increasing infection risk. Potential side effects include headache, diarrhea, and nausea. Report persistent or worsening side effects to your doctor. A patient assistance program exists in India, facilitated by Tata 1mg; inquire with your doctor or call 1800-102-1618 for details.
Uses of Imbruvica 140mg Capsule
Mantle cell lymphoma and chronic lymphocytic leukemia are both blood cancers.
Major Benefits of Imbruvica 140mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Imbruvica 140mg Capsules. These capsules can be administered with or without food, although consistent timing is recommended.
Common Side effects of Imbruvica 140mg Capsule:
- Headache
- Fever
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Nausea
- Low blood platelets
- Decreased white blood cell count (neutrophils)
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Rash
- Anemia (low number of red blood cells)
- Bruising
- Muscle spasm
- Hemorrhage
- Pneumonia
- Cough
- Dry eye
- High blood pressure
- Weight loss
- Urinary tract infection
- Peripheral edema
- Subdural hematoma
- Second primary malignancies
How to use Imbruvica 140mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Imbruvica 140mg Capsules can be administered with or without food, although consistent timing is recommended.
How Imbruvica 140mg Capsule works:
Ibrutinib 140mg capsules, a Bruton's tyrosine kinase inhibitor, halt the activity of a faulty protein driving cancer cell proliferation, thus hindering or slowing cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking Imbruvica 140mg Capsules is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Imbruvica 140mg capsules is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCAUTION
The use of Imbruvica 140mg capsules necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Imbruvica 140mg Capsules.
KidneyCAUTION
Patients with kidney impairment should use Imbruvica 140mg capsules cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Imbruvica 140mg capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Imbruvica 140mg Capsule :
NA
Facts to Know About Imbruvica 140mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Diphenyl ether derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | BTK inhibitors |
3,018 People bought this recently
